Altisource Asset Management (AAMCF) 10-Q 13 May 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2022	May 06, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-36063
Entity Registrant Name	Altisource Asset Management Corporation
Entity Incorporation, State or Country Code	VI
Entity Tax Identification Number	66-0783125
Entity Address, Address Line One	5100 Tamarind Reef
Entity Address, City or Town	Christiansted
Entity Address, Country	VI
Entity Address, Postal Zip Code	00820
City Area Code	704
Local Phone Number	275-9113
Title of 12(b) Security	Common stock, par value $0.01 per share
Trading Symbol	AAMC
Security Exchange Name	NYSEAMER
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,061,411
Entity Central Index Key	0001555074
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 54,370	$ 78,349
Loans held for investment, at fair value	12,223	0
Prepaid expenses and other assets	1,752	1,837
Total current assets	68,345	80,186
Non-current assets:
Loans held for investment, at fair value	5,500	0
Right-of-use lease assets	785	825
Other non-current assets	355	465
Total non-current assets	6,640	1,290
Total assets	74,985	81,476
Current liabilities:
Accrued salaries and employee benefits	814	983
Accounts payable and accrued liabilities	4,150	3,465
Short-term lease liabilities	144	139
Total current liabilities	5,108	4,587
Non-current liabilities:
Long-term lease liabilities	677	720
Other non-current liabilities	0	2,697
Total non-current liabilities	677	3,417
Total liabilities	5,785	8,004
Commitments and contingencies (Note 6)	0	0
Redeemable preferred stock:
Preferred stock, $0.01 par value, 250,000 shares authorized as of March 31, 2022 and December 31, 2021. 144,212 shares issued and outstanding and $144,212 redemption value as of March 31, 2022 and 150,000 shares issued and outstanding and $150,000 redemption value as of December 31, 2021.	144,212	150,000
Stockholders' deficit:
Common stock, $0.01 par value, 5,000,000 authorized shares; 3,422,391 and 2,061,411 shares issued and outstanding, respectively, as of March 31, 2022 and 3,416,541 and 2,055,561 shares issued and outstanding, respectively, as of December 31, 2021.	34	34
Additional paid-in capital	148,742	143,523
Retained earnings	53,753	57,450
Accumulated other comprehensive loss	48	54
Treasury stock, at cost, 1,360,980 shares as of March 31, 2022 and December 31, 2021.	(277,589)	(277,589)
Total stockholders' deficit	(75,012)	(76,528)
Total liabilities and equity	$ 74,985	$ 81,476

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	250,000	250,000
Preferred stock, shares issued (in shares)	144,212	150,000
Preferred stock, shares outstanding (in shares)	144,212	150,000
Preferred stock, redemption value	$ 144,212	$ 150,000
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	5,000,000	5,000,000
Common stock, shares issued (in shares)	3,422,391	3,416,541
Common stock, shares outstanding (in shares)	2,061,411	2,055,561
Treasury stock, shares (in shares)	1,360,980	1,360,980

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Expenses:
Salaries and benefits	$ 924,000	$ 3,545,000
Legal fees	1,357,000	1,336,000
Professional fees	266,000	549,000
General and administrative	729,000	753,000
Acquisition charges	424,000	0
Total expenses	3,700,000	6,183,000
Other (loss) income:
Change in fair value of Front Yard common stock	0	146,000
Foreign exchange gain, net	2,000	0
Change in fair value of equity securities	0	5,721,000
Dividend income	0	2,154,000
Interest expense	0	(36,000)
Other income	6,000	135,000
Total other income	8,000	8,120,000
Net (loss) income from continuing operations before income taxes	(3,692,000)	1,937,000
Income tax expense	5,000	2,294,000
Net loss from continuing operations	(3,697,000)	(357,000)
Discontinued operations:
Gain on disposal of operation related to Front Yard	0	7,485,000
Income tax expense related to disposal	0	1,272,000
Net gain on discontinued operations	0	6,213,000
Net (loss) income attributable to common stockholders	(3,697,000)	5,856,000
Continuing operations earnings per share
Net loss from continuing operations	(3,697,000)	(357,000)
Gain on preferred stock transaction	5,122,000	71,883,000
Numerator for earnings per share from continuing operations	1,425,000	71,526,000
Discontinued operations earnings per share
Net income from discontinued operations	$ 0	$ 6,213,000
Earnings per share of common stock – basic:
Continuing operations – basic (usd per share)	$ 0.69	$ 38.78
Discontinued operations – basic (usd per share)	0	3.37
Earnings per basic common share (usd per share)	$ 0.69	$ 42.15
Weighted average common stock outstanding – basic (in shares)	2,056,666	1,844,212
Earnings per share of common stock – diluted:
Continuing operations – diluted (usd per share)	$ 0.66	$ 34.42
Discontinued operations – diluted (usd per share)	0	2.99
Earnings per diluted common share (usd per share)	$ 0.66	$ 37.41
Weighted average common stock outstanding – diluted (in shares)	2,174,002	2,078,077

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (3,697)	$ 5,856
Other comprehensive loss:
Currency translation adjustments, net	(6)	(2)
Total other comprehensive loss:	(6)	(2)
Comprehensive (loss) income:	$ (3,703)	$ 5,854

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2020		2,966,207
Beginning balance at Dec. 31, 2020	$ (166,578)	$ 30	$ 46,574	$ 63,426	$ (65)	$ (276,543)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued under share-based compensation plans, net of shares withheld for employee taxes (in shares)		153,429
Common shares issued under share-based compensation plans, net of shares withheld for employee taxes	(800)	$ 2	(2)			(800)
Share-based compensation, net of tax	2,227		2,446			(219)
Currency translation adjustments, net	(2)				(2)
Acquisition and disposition of subsidiaries	153			28	125
Preferred stock conversion (in shares)		288,283
Preferred stock conversion	78,937	$ 2	78,935
Net (loss) income	5,856			5,856
Ending balance (in shares) at Mar. 31, 2021		3,407,919
Ending balance at Mar. 31, 2021	$ (80,207)	$ 34	127,953	69,310	58	(277,562)
Beginning balance (in shares) at Dec. 31, 2021	2,055,561	3,416,541
Beginning balance at Dec. 31, 2021	$ (76,528)	$ 34	143,523	57,450	54	(277,589)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued under share-based compensation plans, net of shares withheld for employee taxes (in shares)		5,850
Common shares issued under share-based compensation plans, net of shares withheld for employee taxes	25		25
Share-based compensation, net of tax	72		72
Currency translation adjustments, net	(6)				(6)
Preferred stock conversion	5,122		5,122
Net (loss) income	$ (3,697)			(3,697)
Ending balance (in shares) at Mar. 31, 2022	2,061,411	3,422,391
Ending balance at Mar. 31, 2022	$ (75,012)	$ 34	$ 148,742	$ 53,753	$ 48	$ (277,589)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities:
Net (loss) income attributable to common stockholders	$ (3,697)	$ 5,856
Net income from discontinued operations	0	6,213
Loss from continuing operations	(3,697)	(357)
Adjustments to reconcile net (loss) income from continuing operations to net cash operating activities:
Depreciation	73	83
Change in fair value of Front Yard common stock	0	(146)
Share-based compensation	72	2,446
Amortization of operating lease right-of-use assets	40	33
Dividend income	0	(2,154)
Change in fair value of equity securities	0	(5,722)
Changes in operating assets and liabilities, net of effects from discontinued operations and acquisition of subsidiary:
Receivable from Front Yard	0	3,414
Prepaid expenses and other assets	5	(982)
Other non-current assets	37	1,657
Accrued salaries and employee benefits	(157)	(2,134)
Accounts payable and accrued liabilities	(714)	(7,632)
Other non-current liabilities and operating lease liabilities	(38)	3,777
Interest payable	0	36
Net cash used in continuing operations	(4,379)	(7,681)
Net cash provided by discontinued operations	0	5,439
Net cash used in operating activities	(4,379)	(2,242)
Investing activities:
Purchase of equity securities	0	(96,950)
Purchase of loans held for investment	(17,723)	0
Dividends received	0	142
Proceeds from sale of equity securities	0	47,501
Investment in property and equipment	0	(511)
Net cash used in continuing operations	(17,723)	(49,818)
Net cash provided by discontinued operations	0	511
Net cash used in investing activities	(17,723)	(49,307)
Financing activities:
Proceeds from borrowed funds	0	28,549
Repayment of borrowed funds	0	(142)
Conversion of preferred stock	(1,893)	(2,868)
Proceeds and payment of tax withholding on stock options exercised, net	25	4
Shares withheld for taxes upon vesting of restricted stock	0	(1,019)
Net payment to subsidiaries included in disposal group	0	(80)
Net cash (used in) provided by continuing operations	(1,868)	24,444
Net cash provided by discontinued operations	0	80
Net cash (used in) provided by financing activities	(1,868)	24,524
Net change in cash and cash equivalents	(23,970)	(27,025)
Effect of exchange rate changes on cash and cash equivalents	(9)	120
Consolidated cash and cash equivalents, beginning of period	78,349	41,807
Consolidated cash and cash equivalents, end of the period	54,370	14,902
Supplemental disclosure of cash flow information (continuing and discontinued operations):
Income taxes paid	5	89
Right-of-use lease assets recognized - operating leases	$ 0	$ 308

Organization and Basis of Prese

Organization and Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	Organization and Basis of Presentation Altisource Asset Management Corporation (“we,” “our,” “us,” or the “Company”) was incorporated in the U.S. Virgin Islands (“USVI”) on March 15, 2012 (our “inception”) and commenced operations on December 21, 2012.Our primary business was to provide asset management and certain corporate governance services to institutional investors. In October 2013, we applied for and were granted registration by the Securities and Exchange Commission (the “SEC”) as a registered investment adviser under Section 203(c) of the Investment Advisers Act of 1940. We historically operated in a single segment focused on providing asset management and certain corporate governance services to investment vehicles. Our primary client was Front Yard Residential Corporation (“Front Yard”), a public real estate investment trust (“REIT”) focused on acquiring and managing quality, affordable single-family rental (“SFR”) properties throughout the United States. On August 13, 2020, we entered into a Termination and Transition Agreement (the “Termination Agreement”) with Front Yard and Front Yard Residential L.P. (“FYR LP”) to terminate the Amended and Restated Asset Management Agreement, dated as of May 7, 2019 (the “Amended AMA”), by and among Front Yard, FYR LP and AAMC, and to provide for a transition plan to facilitate the internalization of Front Yard’s asset management function (the “Transition Plan”). The Termination Agreement was effective on December 31, 2020, the date that the parties mutually agreed that the Transition Plan had been satisfactorily completed (the “Termination Date”) and, the Amended AMA was terminated in its entirety. As disclosed in our public filings, the Company’s prior business operations ceased in the first week of 2021. During 2021, the Company engaged in a comprehensive search to acquire an operating company with the proceeds received from the sale of its operations in accordance with the Termination Agreement. A range of industries were included in the search, including, but not limited to, real estate lending, cryptocurrency, block-chain technology and insurance operations. Outside professional firms, including among others, Cowen and Company, LLC, an investment bank, and Norton Rose Fulbright LLP, a global law practice, were engaged to provide due diligence, legal and valuation expertise to assist in our search. In March 2022, AAMC created the Alternative Lending Group (ALG). The Company has committed $40 million to grow the operations of the ALG to perform the following: • Build out a niche origination platform as well as a loan acquisition team; • Fund the originated or acquired alternative loans from a combination of Company equity and future lines of credit; • Sell the originated and acquired alternative loans through forward commitment and repurchase contracts; • Leverage senior management’s expertise in this space; and • Utilize AAMC’s existing operations in India to drive controls and cost efficiencies. ALG's primary sources of income will be derived from mortgage banking activities generated through the origination and acquisition of loans, and their subsequent sale or securitization as well as net interest income from loans while held on the balance sheet for investment. In addition to ALG operations, AAMC has also committed to $2.0 million of initial capital to invest into a Crypto ATM business through its Right of First Refusal Agreement with the cryptocurrency company, ForumPay, with the intent to deploy crypto enabled ATMs worldwide. The Crypto ATMs using ForumPay's software will generally allow users to purchase multiple cryptocurrencies such as Bitcoin, Ethereum and Litecoin, using fiat currency, sell the same cryptocurrencies and eventually remit payments globally either in cryptocurrency or the local fiat currency. The Company will earn revenue by charging fees for utilizing the ATMs for exchange between cryptocurrency and local fiat currency. We will initially invest $2.0 million and plan to invest more as the opportunity warrants. Basis of presentation and use of estimates The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. All wholly owned subsidiaries are included, and all intercompany accounts and transactions have been eliminated. In management's opinion, the unaudited interim condensed consolidated financial statements contain all adjustments that are of a normal recurring nature and are necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. The interim results are not necessarily indicative of results for a full year. We have omitted certain notes and other information from the interim condensed consolidated financial statements presented in this Quarterly Report on Form 10-Q as permitted by SEC rules and regulations. These condensed consolidated financial statements should be read in conjunction with our annual consolidated financial statements included within our Annual Report on Form 10-K for the year ended December 31, 2021. Use of estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Loans held for investment or sale, carried at fair market value We will both originate or purchase alternative loans. These loans will either be classified as held for investment or held for sale depending upon the determination of management. We have elected to measure these alternative loans at fair value on a loan by loan basis. This option is available when we first recognize a financial asset. Subsequent changes in the fair value of these loans will be recorded in our condensed consolidated statements of operations in the period of the change. A fair value measurement represents the price at which an orderly transaction would occur between willing market participants at the measurement date. We will estimate the fair values of the loans held for investment or sale based on available inputs from the marketplace. The market for the loans that we have or will invest in is generally illiquid. Establishing fair values for illiquid assets is inherently subjective and is often dependent upon our estimates and modeling assumptions. In circumstances where relevant market inputs cannot be obtained, increased analysis and management judgment are required to estimate fair value. This generally requires us to establish internal assumptions about future cash flows and appropriate risk-adjusted discount rates. Regardless of the valuation inputs we apply, the objective of fair value measurement for assets is unchanged from what it would be if markets were operating at normal activity levels and/or transactions were orderly; that is, to determine the current exit price. See Note 3 for further discussion on fair value measurements. Interest for these loans is recognized as revenue when earned and deemed collectible or until a loan becomes more than 90 days past due, at which point the loan is placed on nonaccrual status and any accrued interest is reversed against interest income. When a seriously delinquent loan previously placed on nonaccrual status has been cured, meaning all delinquent principal and interest have been remitted by the borrower, the loan will be placed back on accrual status. Redeemable Preferred stock Issuance of Series A Convertible Preferred Stock in 2014 Private Placement During the first quarter of 2014, we issued 250,000 shares of convertible preferred stock for $250.0 million (“Series A Shares”) to institutional investors. Under the Certificate of Designations of the Series A Shares (the “Certificate”), we have the option to redeem all of the Series A Shares on March 15, 2020 and on each successive five-year anniversary of March 15, 2020 thereafter. In connection with these same redemption dates, each holder of our Series A Shares has the right to give notice requesting us to redeem all of the Series A Shares held by such holder out of legally available funds. In accordance with the terms of the Certificate, if we have legally available funds to redeem all, but not less than all, of the Series A Shares requested to be redeemed on a redemption date, we will deliver to those holders who have requested redemption in accordance with the Certificate a notice of redemption. If we do not have legally available funds to redeem all, but not less than all, of the Series A Shares requested to be redeemed on a redemption date, we will not provide a notice of redemption. The redemption right will be exercisable in connection with each redemption date every five years until the mandatory redemption date in 2044. If we are required to redeem all of the holder's Series A Shares, we are required to do so for cash at a price equal to $1,000 per share (the issuance price) out of funds legally available therefor. Due to the redemption provisions of the Series A Preferred Stock, we classify these shares as mezzanine equity, outside of permanent stockholders' equity. The holders of our Series A Shares are not entitled to receive dividends with respect to their Series A Shares. The Series A Shares are convertible into shares of our common stock at a conversion price of $1,250 per share (or an exchange rate of 0.8 shares of common stock for Series A Share), subject to certain anti-dilution adjustments. Upon certain change of control transactions or upon the liquidation, dissolution or winding up of the Company, holders of the Series A Shares will be entitled to receive an amount in cash per Series A Share equal to the greater of: (i) $1,000 plus the aggregate amount of cash dividends paid on the number of shares of common stock into which such Series A Shares were convertible on each ex-dividend date for such dividends; and (ii) The number of shares of common stock into which the Series A Shares are then convertible multiplied by the then-current market price of the common stock. The Certificate confers no voting rights to holders, except with respect to matters that materially and adversely affect the voting powers, rights or preferences of the Series A Shares or as otherwise required by applicable law. With respect to the distribution of assets upon the liquidation, dissolution or winding up of the Company, the Series A Shares rank senior to our common stock and on parity with all other classes of preferred stock that may be issued by us in the future. The Series A Shares are recorded net of issuance costs, which were amortized on a straight-line basis through the first potential redemption date in March 2020. Between January 31, 2020 and February 3, 2020, we received purported notices from all of the holders of our Series A Shares requesting us to redeem an aggregate of $250.0 million liquidation preference of our Series A Shares on March 15, 2020. We did not have legally available funds to redeem all of the Series A Shares on March 15, 2020. As a result, we do not believe, under the terms of the Certificate, that we were obligated to redeem any of the Series A Shares under the Certificate. Current Litigation – Luxor (plaintiff) v. AAMC (defendant) On February 3, 2020, Luxor filed a complaint in the Supreme Court of the State of New York, County of New York, against AAMC for breach of contract, specific performance, unjust enrichment, and related damages and expenses. The complaint alleges that AAMC’s position that it will not redeem any of Luxor’s Series A Shares on the March 15, 2020 redemption date is a material breach of AAMC’s redemption obligations under the Certificate. Luxor seeks an order requiring AAMC to redeem its Series A Shares, recovery of no less than $144,212,000 in damages, which is equal to the amount Luxor would receive if AAMC redeemed all of Luxor’s Series A Shares at the redemption price of $1,000 per share set forth in the Certificate, as well as payment of its costs and expenses in the lawsuit. In the alternative, Luxor seeks a return of its initial purchase price of $150,000,000 for the Series A Shares, as well as payment of its costs and expenses in the lawsuit. On May 25, 2020, Luxor’s complaint was amended to add Putnam Equity Spectrum Fund and Putnam Capital Spectrum Fund (collectively, “Putnam”), which also invested in the Series A Shares, as plaintiff. On June 12, 2020, AAMC moved to dismiss the Amended Complaint in favor of AAMC’s first-filed declaratory judgment action in the U.S. Virgin Islands. On August 4, 2020, the court denied AAMC’s motion to dismiss. On February 17, 2021, in accordance with the terms of the Putnam Agreement described below, Putnam agreed to discontinue all claims against AAMC with prejudice related to the Series A shares. Luxor and AAMC have completed discovery in the action and summary judgment motions are currently scheduled to be filed by June 23, 2022. – AAMC (plaintiff) v. Luxor (defendant) On January 27, 2020, AAMC filed a complaint for declaratory judgment relief in the Superior Court of the Virgin Islands, Division of St. Croix (“Superior Court”), against Luxor Capital Group, LP and certain of its funds and managed accounts (collectively, “Luxor”) regarding AAMC’s redemption obligations under the Certificate. Pursuant to the Certificate, holders of the Series A Shares are permitted on March 15, 2020 and on each successive five-year anniversary of March 15, 2020 to request AAMC, upon not less than 15 nor more than 30 business days’ prior notice, to redeem all but not less than all of their Series A Shares out of legally available funds. AAMC sought a declaration that AAMC is not required to redeem any of Luxor’s Series A Shares on a redemption date if AAMC does not have legally available funds to redeem all of Luxor’s Series A Shares on such redemption date. Luxor removed the action to the U.S District Court for the Virgin Islands, and, on March 24, 2020, AAMC moved to remand the action back to the Superior Court. On May 15, 2020, Luxor moved to dismiss AAMC's declaratory judgment complaint. Both motions had been fully briefed and submitted to the Court as of July 29, 2020. Due to the more advanced status of the case in New York and the similar issues in the two cases, AAMC determined to terminate the action in the Superior Court and on May 5, 2022, the parties jointly filed a voluntary dismissal of the action without prejudice. – Luxor Books and Records Demand On April 26, 2021, Luxor, sent a letter to the Company demanding, under the common law of the USVI, the right to inspect certain books and records of the Company (the “Demand”). According to Luxor, the purpose of the Demand is to investigate whether the Company’s Board of Directors may have considered or engaged in transactions with or at the direction of a significant shareholder of the Company or whether the Company’s Board of Directors and/or Company management may have mismanaged the Company or engaged in wrongdoing, may not have properly discharged their fiduciary duties, or may have conflicts of interest. Luxor further alleges that it seeks an inspection of the Company books and records to determine whether the current directors should continue to serve on the Company’s board or whether a derivative suit should be filed. On May 10, 2021, the Company sent a letter responding to the Demand and declining to provide the Company’s books and records for inspection (the “Response”). The Response states that Luxor does not have a credible basis for the Demand, which is required under the USVI common law; that, as preferred shareholders with no voting rights, Luxor’s purpose for the Demand is not reasonably related to Luxor’s interests as shareholders of the Company because Luxor cannot vote in connection with Board elections or business transactions of the Company; and that Luxor’s Demand serves only to personally benefit Luxor in its private suit against the Company. AAMC intends to continue to pursue its strategic business initiatives despite this litigation. If Luxor were to prevail in its lawsuit, we may need to cease or curtail our business initiatives and our liquidity could be materially and adversely affected Settlement Activities On February 17, 2021, the Company entered into a settlement agreement dated as of February 17, 2021 (the “Putnam Agreement”) with Putnam. Pursuant to the Putnam Agreement, AAMC and Putnam exchanged all of Putnam’s 81,800 Series A Shares for 288,283 shares of AAMC’s common stock. Additionally, AAMC paid Putnam $1,636,000 within three On August 27, 2021, the Company entered into a settlement agreement (the “Wellington Agreement”) with certain funds managed by Wellington Management Company LLP (collectively, “Wellington”). Under the Wellington Agreement, the Company paid Wellington $2,093,000 in exchange for 18,200 Series A Shares ($18.2 million of liquidation preference) held by Wellington , and in return Wellington agreed to release AAMC from all claims related to the Series A Shares . As a result of this settlement, we recognized a one-time gain directly to Additional paid in capital of $16.1 million gain in the third quarter of 2021. On January 6, 2022, the Company entered into a settlement agreement (the "Settlement Agreement") with two institutional investors. Under the Settlement Agreement, the Company paid the institutional investors approximately $665 thousand in cash in exchange for 5,788 Series A shares ($5.79 million of liquidation preference) held by the institutional investors. As a result of this settlement, the Company recognized a gain of approximately $5.1 million to Additional paid in capital in the first quarter of 2022. Recently issued accounting standards Recently issued accounting standards adopted In December 2019, the FASB issued ASU 2019-12, Income Taxes - Simplifying the Accounting for Income Taxes (Topic 740), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. Our adoption of this standard in the first quarter of 2022 did not have a material impact on our financial statements. Recently issued accounting standards not yet adopted In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides practical expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments in this update apply only to contracts, hedging relationships, and other transactions that reference the London interbank offered rate (“LIBOR”) or another reference rate expected to be discontinued as a result of reference rate reform. These amendments are not applicable to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. ASU No. 2020-04 is effective as of March 12, 2020 through December 31, 2022 and may be applied to contract modifications and hedging relationships from the beginning of an interim period that includes or is subsequent to March 12, 2020. We will adopt this standard when LIBOR is discontinued. We are evaluating the impact the new standard will have on our consolidated financial statements and related disclosures, but do not anticipate a material impact.

Discontinued Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations Our primary client prior to December 31, 2020 had been Front Yard Residential Corporation (“Front Yard”), a public real estate investment trust (“REIT”) focused on acquiring and managing quality, affordable single-family rental (“SFR”) properties throughout the United States. All of our revenue for all periods presented prior to December 31, 2021 was generated through our asset management agreements with Front Yard. On August 13, 2020, AAMC and Front Yard entered into a Termination and Transition Agreement (the “Termination Agreement”), pursuant to which the Company and Front Yard have agreed to effectively internalize the asset management function of Front Yard. The Termination Agreement provided that the Amended AMA would terminate following a transition period to enable the internalization of Front Yard’s asset management function, allow for the assignment of certain vendor contracts and implement the transfer of certain employees to Front Yard and the training of required replacement employees at each company. In addition, Front Yard acquired the equity interests of AAMC's Indian subsidiary, the equity interests of AAMC's Cayman Islands subsidiary, the right to solicit and hire designated AAMC employees that oversaw the management of Front Yard's business and other assets of AAMC that were used in connection with the operation of Front Yard's business. The transition period ended at the close of business, December 31, 2020, the time that AAMC and Front Yard mutually agreed that all required transition activities had been successfully completed (the “Termination Date”). On the Termination Date, the Amended AMA terminated, and the Company completed the assignment of our lease in Charlotte, North Carolina to Front Yard. Additionally, on December 31, 2020, we completed the sale of our Cayman Islands subsidiary. On January 1, 2021, in connection with the Termination Agreement, the Company completed the sale of our India subsidiary. The Company had no assets and liabilities related to our discontinued operations that constituted the Disposal Group at March 31, 2022 and December 31, 2021. Discontinued operations includes (i) the management fee revenues generated under our asset management agreements with Front Yard, (ii) expense reimbursements from Front Yard and the underlying expenses, (iii) the results of operations of our India and Cayman Islands subsidiaries, (iv) the employment costs associated with certain individuals wholly dedicated to Front Yard and (v) the costs associated with our lease in Charlotte, North Carolina, that was assumed by Front Yard on December 31, 2020. The operating results of these items are presented in our consolidated statements of operations as discontinued operations for all periods presented and revenues and expenses directly related to discontinued operations were eliminated from our ongoing operations. The following condensed table details the components comprising net income from our discontinued operations ($ in thousands): Three months ended March 31, 2022 2021 Other income from discontinued operations: Gain on disposal — 7,485 Total other income from discontinued operations — 7,485 Net income from discontinued operations before income taxes — 7,485 Income tax expense — 1,272 Net income from discontinued operations $ — $ 6,213 The following table details cash flow information related to our discontinued operations for the periods indicated ($ in thousands): Three months ended March 31, 2022 2021 Total operating cash flows from discontinued operations $ — $ 5,439 Total investing cash flows from discontinued operations — 511 Total financing cash flows from discontinued operations — 80

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Our initial loan portfolio was acquired on March 31, 2022. As these loans were purchased on the balance sheet date, the purchase price of the loans is deemed to be the fair market value. Future changes in fair value will be recurring and reported through our condensed consolidated statements of operations on a quarterly basis in the period of the change. Of the loans purchased, 2 loans represent 65% of the outstanding balance as of March 31, 2022. For financial reporting purposes of our alternative loans, we will follow a fair value hierarchy established under GAAP that is used to determine the fair value of financial instruments. This hierarchy prioritizes relevant market inputs in order to determine an "exit price" at the measurement date, or at the price at which an asset could be sold or a liability could be transferred in an orderly process that is not a forced liquidation or distressed sale. Level 1 inputs are observable inputs that reflect quoted prices for identical assets or liabilities in active markets. Level 2 inputs are observable inputs other than quoted prices for an assets or liabilities that are obtained through corroboration with observable market data. Level 3 inputs are unobservable inputs (e.g., our own data or assumptions) that are used when there is little, if any, relevant market activity for the asset or liability required to be measured at fair value. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. Our assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. The following table presents the assets that are reported at fair value on a recurring basis as of March 31, 2022, as well as the fair value of hierarchy of the valuation inputs used to measure fair value. We did not have any assets that were reported at fair value as of December 31, 2021. We did not have any liabilities to report as of March 31, 2022 and December 31, 2021. March 31, 2022 Carrying Fair Value Measurements Using (In thousands) Value Level 1 Level 2 Level 3 Assets Loans held for investment $ 17,723 $ — $ — $ 17,723 As of March 31, 2022, the Company had no securities outstanding. We did not transfer any assets from one level to another level during the year ended December 31, 2021. Investment gains/losses in the three months ended of 2021 and 2020 are summarized as follows ($ in thousands): Three months ended March 31, 2022 2021 Equity securities: Change in unrealized gains (losses) during the period on securities held at the end of the end of the period $ — $ 5,721 Front Yard common stock: Investment gains on securities sold during the period — 146 Total change in fair value of equity securities and Front Yard common stock $ — $ 5,867 Investment gains and losses include unrealized gains and losses from changes in fair values during the period on positions that we owned in 2021, as well as gains and losses on positions sold during the period. As reflected in the condensed consolidated statements of cash flows, we received proceeds from sales of Front Yard common stock of $47.5 million in the three months ended March 31, 2021. No proceeds were received in three months ended March 31, 2022 because no investments were held. In the preceding table, investment gains/losses on equity securities sold during the period reflect the difference between the sales proceeds and the fair value of the equity securities sold at the beginning of the applicable quarterly period.

Borrowings

Borrowings	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Borrowings	BorrowingsIn 2021, the Company began borrowing under a standard margin arrangement with our banking institution. The margin account is secured by the securities held in our brokerage account with this institution. We paid interest on all of our borrowings each month when a balance was owed. All indebtedness on the margin agreement was paid off as of December 31, 2021. The Company had no borrowings outstanding at March 31, 2022 or December 31, 2021.

Leases

Leases	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	Leases We lease office space under operating leases in Christiansted, St. Croix, U.S. Virgin Islands, and Bengaluru, India. As of March 31, 2022 and December 31, 2021, our weighted average remaining lease term, including applicable extensions, was 4.8 years and 5.1 years, respectively, and we applied a discount rate of 7.0% and 7.0%, respectively, to our office leases. We determine the discount rate for each lease to be either the discount rate stated in the lease agreement or our estimated rate that we would be charged to finance real estate assets. During the three months ended March 31, 2022 and 2021, we recognized rent expense of $49,000 and $50,000, related to long-term operating leases, respectively. We have had no short-term rent expense in March 31, 2022 and 2021 reporting periods. We include rent expense as a component of general and administrative expenses in the condensed consolidated statements of operations. We had no finance leases during the three months ended March 31, 2022 and 2021. The following table presents our future lease obligations under our operating leases as of March 31, 2022 ($ in thousands): Operating Lease Liabilities 2022 (1) $ 146 2023 203 2024 207 2025 205 2026 131 Thereafter 75 Total lease payments 967 Less: interest 146 Lease liabilities $ 821 _____________ (1) Excludes the three months ended March 31, 2022.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation, claims and assessments Information regarding reportable legal proceedings is contained in the “Commitments and Contingencies” note in the financial statements provided in our Annual Report on Form 10-K for the year ended December 31, 2021. We establish reserves for specific legal proceedings when we determine that the likelihood of an outcome is probable and the amount of loss can be reasonably estimated. We do not currently have any reserves for our legal proceedings. The following updates and restates the description of the previously reported matters: Litigation regarding Luxor Capital Group, LP and certain of its managed funds and accounts ("Luxor") Please refer to Note 1 – Section Series A Convertible Preferred Stock in 2014 Private Placement. Executive Arbitrations Former Chief Executive Officer, Indroneel Chatterjee On May 3, 2021, Mr. Chatterjee, commenced an arbitration against the Company and each of its directors. The arbitration complaint alleges that the Company’s April 16, 2021 for cause termination of Mr. Chatterjee was in breach of Mr. Chatterjee’s Amended and Restated Employment Agreement and made extra contractual claims against the Company for not affording Mr. Chatterjee a “fair procedure” and placed him in a “false light” by disclosing Mr. Chatterjee’s termination in its public announcement of the for cause termination. In addition, the arbitration complaint also asserts a tort claim against each of the Company’s directors relating to that termination and against the Company for its April 16, 2021 public announcement of the for cause termination. Mr. Chatterjee’s arbitration complaint seeks unspecified damages for his contract claims including for loss of income, stock and bonus, and punitive damages on his tort claims. On June 10, 2021, the Company and its directors responded to the arbitration complaint and advanced counterclaims against Mr. Chatterjee. On October 20, 2021, the arbitrator granted the Company’s motion to dismiss with respect to Mr. Chatterjee’s “fair procedure” and “false light” claims, but denied the motion to dismiss the tort claim against each of the directors. The arbitrator has set a trial date for October 24-28, 2022. The Company and the directors intend to vigorously defend the claims. Erbey Holding Corporation et al. v. Blackrock Management Inc., et al. On April 12, 2018, a partial stockholder derivative action was filed in the Superior Court of the Virgin Islands, Division of St. Croix under the caption Erbey Holding Corporation, et al. v. Blackrock Financial Management Inc., et al. The action was filed by Erbey Holding Corporation (“Erbey Holding”), John R. Erbey Family Limited Partnership (“JREFLP”), by its general partner Jupiter Capital, Inc., Salt Pond Holdings, LLC (“Salt Pond”), Munus, L.P. (“Munus”), Carisma Trust (“Carisma”), by its trustee, Venia, LLC, and Tribue Limited Partnership (collectively, the “Plaintiffs”) each on its own behalf and Salt Pond and Carisma derivatively on behalf of AAMC. The action was filed against Blackrock Financial Management, Inc., Blackrock Investment Management, LLC, Blackrock Investments, LLC, Blackrock Capital Management, Inc., Blackrock, Inc. (collectively, “Blackrock”), Pacific Investment Management Company LLC, PIMCO Investments LLC (collectively, “PIMCO”) and John and Jane Does 1-10 (collectively with Blackrock and PIMCO, the “Defendants”). The action alleges a conspiracy by Blackrock and PIMCO to harm Ocwen Financial Corporation (“Ocwen”) and AAMC and certain of their subsidiaries, affiliates and related companies and to extract enormous profits at the expense of Ocwen and AAMC by attempting to damage their operations, business relationships and reputations. The complaint alleges that Defendants’ conspiratorial activities, which included short-selling activities, were designed to destroy Ocwen and AAMC, and that the Plaintiffs (including AAMC) suffered significant injury, including but not limited to lost value of their stock and/or stock holdings. The action seeks, among other things, an award of monetary damages to AAMC, including treble damages under Section 605, Title IV of the Virgin Islands Code related to the Criminally Influenced and Corrupt Organizations Act, punitive damages and an award of attorney’s and other fees and expenses. Defendants have moved to dismiss the first amended verified complaint. Plaintiffs and AAMC have moved for leave to file a second amended verified complaint to include AAMC as a direct plaintiff, rather than as a derivative party. On March 27, 2019, the Court held oral argument on Defendants' motions to dismiss the first amended verified complaint and Plaintiffs' motion for leave to file the second amended verified complaint. The Court held additional oral argument on the pending motions on October 25, 2021. The Court has not yet decided the pending motions. At this time, we are not able to predict the ultimate outcome of this matter, nor can we estimate the range of possible damages to be awarded to AAMC, if any. As such, we have not recorded a liability for this matter at March 31, 2022 or December 31, 2021. COVID-19 Pandemic Due to the current COVID-19 pandemic in the United States and globally, our business, our employees and the economy as a whole could be adversely impacted. The magnitude and duration of the COVID-19 pandemic and its impact on our cash flows and future results of operations could potentially be significant and will largely depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the COVID-19 pandemic, the success of actions taken to contain or treat the pandemic, and reactions by consumers, companies, governmental entities and capital markets. The COVID-19 pandemic has had significant effects on global markets, supply chains, businesses and communities. As a result of increased COVID-19 vaccination rates and significant reopening of the economy, related risks appear to have decreased. Nevertheless, the Company has taken appropriate actions to mitigate the negative impact the virus has on the Company by reducing employee travel, allowing employees to work remotely, and canceling in-person meetings when possible.

Share-Based Payments

Share-Based Payments	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Share-Based Payments	Share-Based Payments On September 20, 2021, we granted 3,000 shares of restricted stock to management with a weighted average grant date fair value per share of $24.83. The restricted stock units will vest in three equal annual installments on September 20, 2022, 2023 and 2024 subject to forfeiture or acceleration. On June 28, 2021, we granted 5,000 shares of restricted stock to management with a weighted average grant date fair value per share of $19.64. The restricted stock units will vest in three equal annual installments on June 28, 2022, 2023 and 2024 subject to forfeiture or acceleration. On February 24, 2021, we granted 82,671 shares of restricted stock to members of management with a weighted average grant date fair value per share of $26.25. The restricted stock units immediately vested. On October 15, 2020, we granted 10,000 shares of restricted stock to former members of management with a weighted average grant date fair value per share of $19.29. The restricted stock units were to vest in three equal annual installments, on October 15, 2021, 2022, and 2023. These shares were forfeited in April 2021 upon their resignations. On January 30, 2020, in order to induce our former Chief Executive Officer to join the Company, we granted 60,000 shares of restricted stock and 60,000 stock options to our former Chief Executive Officer. The restricted stock and stock options had a weighted average grant date fair value of $13.11 and $10.61, respectively. The restricted stock units will vest in three equal annual installments on January 30, 2021, 2022, and 2023. On April 16, 2021, the former Chief Executive Officer was terminated for cause, and as a result, 40,000 unvested restricted stock units and 60,000 unvested options were forfeited at that date. Our Directors each receive annual grants of restricted stock equal to $60,000 based on the market value of our common stock at the time of the annual stockholders meeting. These shares of restricted stock vest and are issued after a one-year service period, subject to each Director attending at least 75% of the Board and committee meetings. During 2021, we granted 7,236 shares of stock pursuant to our Equity Incentive Plans with a weighted average grant date fair value per share of $24.88. We recorded $0.07 million and $2.4 million of compensation expense related to our share-based compensation for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022 and December 31, 2021, we had an aggregate $0.2 million and $0.3 million, respectively, of total unrecognized share-based compensation cost to be recognized over a weighted average remaining estimated term of 1.0 years and 1.2 years, respectively.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We are domiciled in the USVI and are obligated to pay taxes to the USVI on our income. We applied for tax benefits from the USVI Economic Development Commission (“EDC”) and received our certificate of benefits (the “Certificate”), effective as of February 1, 2013. Pursuant to the Certificate, as long as we comply with its provisions, we will receive a 90% tax credit on our USVI-sourced income taxes until 2043. By letter dated December 21, 2020, the EDC approved a temporary waiver (the “Waiver”) of the Company’s minimum employment requirements to five full-time USVI employees for the period from January 1, 2021 to December 31, 2021. At March 31, 2022, the Company had two less USVI employees than what is required under the provisions of the Waiver. The Company is also continuing to seek to hire USVI employees to meet the requirements of the Waiver. The Company's Chief Financial Officer and General Counsel have relocated to the USVI. They will be eligible USVI employees after one year of residency. The Company has hired Jason Kopcak as President and Chief Operating Officer who will begin his employment on or before May 15, 2022. At that time, Mr. Kopcak will relocate to the USVI and will also be an eligible USVI employee after one year of residency. As of March 31, 2022 and December 31, 2021, we accrued no interest or penalties associated with any unrecognized tax benefits, nor did we recognize any interest expense or penalties during the three months ended March 31, 2022 and 2021. The Company recorded tax expense of $5,000 on a book loss of $3.7 million in the three months ended March 31, 2022. The material differences between the effective tax rate and the statutory tax rate are the EDC benefit discussed above and the fact that the USVI EDC is in a full valuation allowance position and incurred a current quarter loss.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table sets forth the components of basic and diluted earnings (loss) per share (in thousands, except share and per share amounts): Three months ended March 31, 2022 2021 Numerator Continuing operations: Net loss from continuing operations $ (3,697) $ (357) Gain on preferred stock transaction 5,122 $ 71,883 Numerator for basic and diluted EPS from continuing operations – net income from continuing operations attributable to common stockholders $ 1,425 $ 71,526 Discontinued operations: Numerator for basic and diluted EPS from discontinued operations - net gain from discontinued operations $ — $ 6,213 Total: Net (loss) income $ (3,697) $ 5,856 Gain on preferred stock transaction $ 5,122 $ 71,883 Numerator for basic and diluted EPS – net income attributable to common stockholders $ 1,425 $ 77,739 Denominator Weighted average common stock outstanding – basic 2,056,666 1,844,212 Weighted average common stock outstanding – diluted 2,174,002 2,078,077 Earnings per share of common stock – basic: Continuing operations – basic $ 0.69 $ 38.78 Discontinued operations – basic — 3.37 Earnings per basic common share $ 0.69 $ 42.15 Earnings per share of common stock – diluted: Continuing operations – diluted $ 0.66 $ 34.42 Discontinued operations – diluted — 2.99 Earnings per diluted common share $ 0.66 $ 37.41 We excluded the items presented below from the calculation of diluted earnings per share as they were antidilutive to loss per share from continuing operations for the periods indicated ($ in thousands): Three months ended March 31, 2022 2021 Denominator Stock options — 5,879 Restricted stock — 59,252 Preferred stock, if converted — 168,734

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segment Information	Segment Information Our primary business prior to December 31, 2020 was to provide asset management and certain corporate governance services to institutional investors. Because substantially all of our revenue was derived from the services we provided to Front Yard, we operated as a single segment focused on providing asset management and corporate governance services. Currently, ALG is our primary segment which we will be growing in 2022.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsManagement has evaluated the impact of all subsequent events through the issuance of these interim condensed consolidated financial statements and has determined that there were no subsequent events requiring adjustment or disclosure in the financial statements.

Organization and Basis of Pre_2

Organization and Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. All wholly owned subsidiaries are included, and all intercompany accounts and transactions have been eliminated.
Consolidation	In management's opinion, the unaudited interim condensed consolidated financial statements contain all adjustments that are of a normal recurring nature and are necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. The interim results are not necessarily indicative of results for a full year. We have omitted certain notes and other information from the interim condensed consolidated financial statements presented in this Quarterly Report on Form 10-Q as permitted by SEC rules and regulations. These condensed consolidated financial statements should be read in conjunction with our annual consolidated financial statements included within our Annual Report on Form 10-K for the year ended December 31, 2021.
Use of estimates	Use of estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Loans held for investment or sale, carried at fair market value	Loans held for investment or sale, carried at fair market value We will both originate or purchase alternative loans. These loans will either be classified as held for investment or held for sale depending upon the determination of management. We have elected to measure these alternative loans at fair value on a loan by loan basis. This option is available when we first recognize a financial asset. Subsequent changes in the fair value of these loans will be recorded in our condensed consolidated statements of operations in the period of the change. A fair value measurement represents the price at which an orderly transaction would occur between willing market participants at the measurement date. We will estimate the fair values of the loans held for investment or sale based on available inputs from the marketplace. The market for the loans that we have or will invest in is generally illiquid. Establishing fair values for illiquid assets is inherently subjective and is often dependent upon our estimates and modeling assumptions. In circumstances where relevant market inputs cannot be obtained, increased analysis and management judgment are required to estimate fair value. This generally requires us to establish internal assumptions about future cash flows and appropriate risk-adjusted discount rates. Regardless of the valuation inputs we apply, the objective of fair value measurement for assets is unchanged from what it would be if markets were operating at normal activity levels and/or transactions were orderly; that is, to determine the current exit price. See Note 3 for further discussion on fair value measurements.
Loans held for investment or sale, carried at fair market value	Loans held for investment or sale, carried at fair market value We will both originate or purchase alternative loans. These loans will either be classified as held for investment or held for sale depending upon the determination of management. We have elected to measure these alternative loans at fair value on a loan by loan basis. This option is available when we first recognize a financial asset. Subsequent changes in the fair value of these loans will be recorded in our condensed consolidated statements of operations in the period of the change. A fair value measurement represents the price at which an orderly transaction would occur between willing market participants at the measurement date. We will estimate the fair values of the loans held for investment or sale based on available inputs from the marketplace. The market for the loans that we have or will invest in is generally illiquid. Establishing fair values for illiquid assets is inherently subjective and is often dependent upon our estimates and modeling assumptions. In circumstances where relevant market inputs cannot be obtained, increased analysis and management judgment are required to estimate fair value. This generally requires us to establish internal assumptions about future cash flows and appropriate risk-adjusted discount rates. Regardless of the valuation inputs we apply, the objective of fair value measurement for assets is unchanged from what it would be if markets were operating at normal activity levels and/or transactions were orderly; that is, to determine the current exit price. See Note 3 for further discussion on fair value measurements.
Recently issued accounting standards	Recently issued accounting standards Recently issued accounting standards adopted In December 2019, the FASB issued ASU 2019-12, Income Taxes - Simplifying the Accounting for Income Taxes (Topic 740), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. Our adoption of this standard in the first quarter of 2022 did not have a material impact on our financial statements. Recently issued accounting standards not yet adopted In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides practical expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments in this update apply only to contracts, hedging relationships, and other transactions that reference the London interbank offered rate (“LIBOR”) or another reference rate expected to be discontinued as a result of reference rate reform. These amendments are not applicable to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. ASU No. 2020-04 is effective as of March 12, 2020 through December 31, 2022 and may be applied to contract modifications and hedging relationships from the beginning of an interim period that includes or is subsequent to March 12, 2020. We will adopt this standard when LIBOR is discontinued. We are evaluating the impact the new standard will have on our consolidated financial statements and related disclosures, but do not anticipate a material impact.

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	The following condensed table details the components comprising net income from our discontinued operations ($ in thousands): Three months ended March 31, 2022 2021 Other income from discontinued operations: Gain on disposal — 7,485 Total other income from discontinued operations — 7,485 Net income from discontinued operations before income taxes — 7,485 Income tax expense — 1,272 Net income from discontinued operations $ — $ 6,213 The following table details cash flow information related to our discontinued operations for the periods indicated ($ in thousands): Three months ended March 31, 2022 2021 Total operating cash flows from discontinued operations $ — $ 5,439 Total investing cash flows from discontinued operations — 511 Total financing cash flows from discontinued operations — 80

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Investment Gain/Losses	Investment gains/losses in the three months ended of 2021 and 2020 are summarized as follows ($ in thousands): Three months ended March 31, 2022 2021 Equity securities: Change in unrealized gains (losses) during the period on securities held at the end of the end of the period $ — $ 5,721 Front Yard common stock: Investment gains on securities sold during the period — 146 Total change in fair value of equity securities and Front Yard common stock $ — $ 5,867
Fair Value Measurements, Recurring	The following table presents the assets that are reported at fair value on a recurring basis as of March 31, 2022, as well as the fair value of hierarchy of the valuation inputs used to measure fair value. We did not have any assets that were reported at fair value as of December 31, 2021. We did not have any liabilities to report as of March 31, 2022 and December 31, 2021. March 31, 2022 Carrying Fair Value Measurements Using (In thousands) Value Level 1 Level 2 Level 3 Assets Loans held for investment $ 17,723 $ — $ — $ 17,723

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Schedule of Maturity Analysis of Operating Leases	The following table presents our future lease obligations under our operating leases as of March 31, 2022 ($ in thousands): Operating Lease Liabilities 2022 (1) $ 146 2023 203 2024 207 2025 205 2026 131 Thereafter 75 Total lease payments 967 Less: interest 146 Lease liabilities $ 821 _____________ (1) Excludes the three months ended March 31, 2022.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Components of Diluted Earnings (Loss) Per Share	The following table sets forth the components of basic and diluted earnings (loss) per share (in thousands, except share and per share amounts): Three months ended March 31, 2022 2021 Numerator Continuing operations: Net loss from continuing operations $ (3,697) $ (357) Gain on preferred stock transaction 5,122 $ 71,883 Numerator for basic and diluted EPS from continuing operations – net income from continuing operations attributable to common stockholders $ 1,425 $ 71,526 Discontinued operations: Numerator for basic and diluted EPS from discontinued operations - net gain from discontinued operations $ — $ 6,213 Total: Net (loss) income $ (3,697) $ 5,856 Gain on preferred stock transaction $ 5,122 $ 71,883 Numerator for basic and diluted EPS – net income attributable to common stockholders $ 1,425 $ 77,739 Denominator Weighted average common stock outstanding – basic 2,056,666 1,844,212 Weighted average common stock outstanding – diluted 2,174,002 2,078,077 Earnings per share of common stock – basic: Continuing operations – basic $ 0.69 $ 38.78 Discontinued operations – basic — 3.37 Earnings per basic common share $ 0.69 $ 42.15 Earnings per share of common stock – diluted: Continuing operations – diluted $ 0.66 $ 34.42 Discontinued operations – diluted — 2.99 Earnings per diluted common share $ 0.66 $ 37.41
Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share	We excluded the items presented below from the calculation of diluted earnings per share as they were antidilutive to loss per share from continuing operations for the periods indicated ($ in thousands): Three months ended March 31, 2022 2021 Denominator Stock options — 5,879 Restricted stock — 59,252 Preferred stock, if converted — 168,734

Organization and Basis of Pre_3

Organization and Basis of Presentation - Organization and Basis of Presentation (Details) $ in Millions	1 Months Ended
	Mar. 31, 2022USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Financial commitment to grow operations	$ 40
Investment company, committed capital	$ 2

Organization and Basis of Pre_4

Organization and Basis of Presentation - Loans Held for Investment or Sale, Carried at Fair Market Value (Details)	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Loans receivable, threshold period past due	90 days

Organization and Basis of Pre_5

Organization and Basis of Presentation - Redeemable Preferred Stock (Details)	3 Months Ended
	Mar. 31, 2014USD ($)$ / sharesshares	Mar. 31, 2022shares	Jan. 06, 2022USD ($)	Dec. 31, 2021shares	Feb. 03, 2020USD ($)$ / shares
Class of Stock [Line Items]
Preferred stock, shares issued (in shares) | shares	250,000	144,212		150,000
Proceeds from issuance of convertible preferred stock | $	$ 250,000,000
Temporary equity, redemption period	5 years
Redemption price per share (usd per share) | $ / shares	$ 1,000				$ 1,000
Preferred stock, conversion price per share (in USD per share) | $ / shares	$ 1,250
Exchange ratio for preferred stock to common stock	0.8
Series A preferred stock
Class of Stock [Line Items]
Preferred stock, liquidation preference | $			$ 5,790,000		$ 250,000,000

Organization and Basis of Pre_6

Organization and Basis of Presentation - Current Litigation (Details)	Jan. 06, 2022USD ($)investorshares	Aug. 27, 2021USD ($)shares	Feb. 17, 2021USD ($)shares	Feb. 03, 2020USD ($)$ / shares	Jan. 27, 2020	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)	Mar. 31, 2014$ / shares
Loss Contingencies [Line Items]
Redemption price per share (usd per share) | $ / shares				$ 1,000				$ 1,000
Loss contingency, damages awarded, number of business days to pay			3 days
Preferred stock conversion						$ 5,122,000	$ 78,937,000
Number of institutional investors in settlement agreement | investor	2
Additional Paid-in Capital
Loss Contingencies [Line Items]
Preferred stock conversion			$ 71,900,000			5,122,000	$ 78,935,000
Series A preferred stock
Loss Contingencies [Line Items]
Litigation Settlement, Shares Awarded From Other Party | shares	(5,788)
Preferred stock, liquidation preference	$ 5,790,000			$ 250,000,000
Luxor
Loss Contingencies [Line Items]
Damages sought				150,000,000
AAMC v. Luxor
Loss Contingencies [Line Items]
Threshold period to request company to redeem shares (years)					5 years
Luxor v. AAMC
Loss Contingencies [Line Items]
Gain related to settlement agreement						$ 5,100,000
Luxor v. AAMC | Series A preferred stock
Loss Contingencies [Line Items]
Settlement agreement, amount awarded to other party	$ 665,000
Luxor v. AAMC | Putnam
Loss Contingencies [Line Items]
Loss contingency, damages awarded			1,636,000
Loss contingency, damages awarded, due on one-year anniversary of the effective date of the agreement			$ 1,227,000
Luxor v. AAMC | Putnam | Series A preferred stock
Loss Contingencies [Line Items]
Shares converted (in shares) | shares			81,800
Luxor v. AAMC | Putnam | Common Stock
Loss Contingencies [Line Items]
Shares issued related to conversion of stock (in shares) | shares			288,283
Settlement Agreement with Wellington
Loss Contingencies [Line Items]
Settlement agreement, amount awarded to other party		$ 2,093,000
Gain related to settlement agreement		$ 16,100,000
Settlement Agreement with Wellington | Series A preferred stock
Loss Contingencies [Line Items]
Litigation Settlement, Shares Awarded From Other Party | shares		(18,200)
Preferred stock, liquidation preference		$ 18,200,000
Minimum | Luxor
Loss Contingencies [Line Items]
Damages sought				$ 144,212,000
Minimum | AAMC v. Luxor
Loss Contingencies [Line Items]
Threshold number of business days to give prior notice to redeem shares (days)					15 days
Maximum | AAMC v. Luxor
Loss Contingencies [Line Items]
Threshold number of business days to give prior notice to redeem shares (days)					30 days

Discontinued Operations - Incom

Discontinued Operations - Income Statement (Details) - Discontinued Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Other income from discontinued operations:
Gain on disposal	$ 0	$ 7,485
Total other income from discontinued operations	0	7,485
Net income from discontinued operations before income taxes	0	7,485
Income tax expense	0	1,272
Net income from discontinued operations	$ 0	$ 6,213

Discontinued Operations - Cash

Discontinued Operations - Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]
Total operating cash flows from discontinued operations	$ 0	$ 5,439
Total investing cash flows from discontinued operations	0	511
Total financing cash flows from discontinued operations	$ 0	$ 80

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Additional Information (Details)	3 Months Ended
	Mar. 31, 2022
Two Loans | Loans Receivable | Product Concentration Risk
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Concentration risk, percentage	65.00%

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Fair Value Measurements, Recurring (Details) - Fair value measurements, recurring - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure		$ 0
Liabilities, fair value disclosure	$ 0	0
Loans held for investment		17,723,000
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans held for investment		0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans held for investment		0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans held for investment		$ 17,723,000

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Investment Holdings [Line Items]
Proceeds from sale of equity securities	$ 0	$ 47,501
Common Stock
Investment Holdings [Line Items]
Proceeds from sale of equity securities	$ 0	$ 47,500

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Investment Gain/Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Gain (Loss) on Securities [Line Items]
Change in unrealized gains (losses) during the period on securities held at the end of the end of the period	$ 0	$ 5,721
Total change in fair value of equity securities and Front Yard common stock	0	5,867
Equity Securities
Gain (Loss) on Securities [Line Items]
Change in unrealized gains (losses) during the period on securities held at the end of the end of the period	0	5,721
Common Stock
Gain (Loss) on Securities [Line Items]
Investment gains on securities sold during the period	$ 0	$ 146

Borrowings (Details)

Borrowings (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
Long-term debt	$ 0	$ 0

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Leases [Abstract]
Weighted average remaining lease term	4 years 9 months 18 days		5 years 1 month 6 days
Discount rate	7.00%		7.00%
Rent expense- long term lease	$ 49,000	$ 50,000
Rent expense- short term lease	0	0
Finance lease, liability	$ 0	$ 0

Leases - Maturity Analysis of O

Leases - Maturity Analysis of Operating Leases (Details) $ in Thousands	Mar. 31, 2022USD ($)
Operating Lease Liabilities
2022	$ 146
2023	203
2024	207
2025	205
2026	131
Thereafter	75
Total lease payments	967
Less: interest	146
Lease liabilities	$ 821

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Erbey Holding Corporation et al. v. Blackrock Management Inc., et al.
Loss Contingencies [Line Items]
Loss contingency accrual	$ 0	$ 0

Share-Based Payments (Details)

Share-Based Payments (Details)	Sep. 20, 2021installment$ / sharesshares	Jun. 28, 2021installment$ / sharesshares	Apr. 16, 2021shares	Feb. 24, 2021$ / sharesshares	Oct. 15, 2020installment$ / sharesshares	Jan. 30, 2020installment$ / sharesshares	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested options forfeited (in shares)			60,000
Share-based compensation | $							$ 70,000	$ 2,400,000
Unrecognized share-based compensation | $							$ 200,000		$ 300,000
Weighted average remaining amortization period of unamortized share based compensation							1 year		1 year 2 months 12 days
Co-chief executive officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)						60,000
Weighted average grant date fair value of options granted (usd per share) | $ / shares						$ 10.61
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted stock units forfeited (in shares)			40,000
Restricted stock | Management
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of restricted stock granted (in shares)	3,000	5,000		82,671	10,000
Weighted average grant date fair value of market based restricted stock granted (usd per share) | $ / shares	$ 24.83	$ 19.64		$ 26.25	$ 19.29
Number of annual installments | installment	3	3			3
Restricted stock | Co-chief executive officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of restricted stock granted (in shares)						60,000
Weighted average grant date fair value of market based restricted stock granted (usd per share) | $ / shares						$ 13.11
Number of annual installments | installment						3
Restricted stock | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of restricted stock granted (in shares)									7,236
Weighted average grant date fair value of market based restricted stock granted (usd per share) | $ / shares									$ 24.88
Value of restricted stock granted to directors annually | $							$ 60,000
Required service period for restricted stock							1 year
Director attendance requirement							75.00%

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details)	3 Months Ended
	Mar. 31, 2022USD ($)employee	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)
Income Tax Disclosure [Abstract]
Income tax exemption, percentage	90.00%
Number of employees below the requirement | employee	2
Interest or penalties accrued	$ 0		$ 0
Income tax expense	5,000	$ 2,294,000
Net loss from continuing operations before income taxes	$ 3,692,000	$ (1,937,000)

Earnings Per Share - Components

Earnings Per Share - Components of Diluted Earnings (Loss) per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Numerator
Net loss from continuing operations	$ (3,697)	$ (357)
Gain on preferred stock transaction	5,122	71,883
Numerator for basic and diluted EPS from continuing operations – net income from continuing operations attributable to common stockholders	1,425	71,526
Numerator for basic and diluted EPS from discontinued operations - net gain from discontinued operations	0	6,213
Net (loss) income	(3,697)	5,856
Numerator for basic and diluted EPS – net income attributable to common stockholders	$ 1,425	$ 77,739
Denominator
Weighted average common stock outstanding – basic (in shares)	2,056,666	1,844,212
Weighted average common stock outstanding – diluted (in shares)	2,174,002	2,078,077
Earnings per share of common stock – basic:
Continuing operations – basic (usd per share)	$ 0.69	$ 38.78
Discontinued operations – basic (usd per share)	0	3.37
Earnings per basic common share (usd per share)	0.69	42.15
Earnings per share of common stock – diluted:
Continuing operations – diluted (usd per share)	0.66	34.42
Discontinued operations – diluted (usd per share)	0	2.99
Earnings per diluted common share (usd per share)	$ 0.66	$ 37.41

Earnings Per Share - Antidiluti

Earnings Per Share - Antidilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Stock options
Denominator
Antidilutive shares excluded from computation of earnings per share (in shares)	0	5,879
Restricted stock
Denominator
Antidilutive shares excluded from computation of earnings per share (in shares)	0	59,252
Preferred stock, if converted
Denominator
Antidilutive shares excluded from computation of earnings per share (in shares)	0	168,734

Segment Information (Details)

Segment Information (Details)	3 Months Ended
	Mar. 31, 2022segment
Segment Reporting [Abstract]
Number of operating segments	1